TissueCypher® is the first diagnostic test of its kind that predicts the risk of developing esophageal cancer in patients with Barrett’s Esophagus.
Video - Cernostics TissueCypher® Technology & DDW 2016
Cernostics is focused on delivering the next generation of cancer diagnostics & prognostics through a unique approach to tissue analysis.
Learn about our approach...
Mon-Fri 9am-5pm (EST)